TPL is a cytotoxic drug that showed an effect on positive CD133 and CD44 cancer cells by inhibiting the proliferation of colon cancer which leads to cell cycle arrest and induces apoptosis. The gene discussed is PROM1; the disease is colonic neoplasm.